Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells

Stem Cell Reports

Volumn 3, Issue 2, 2014, Pages 250-259

  Douvaras, Panagiotis ^a   Wang, Jing ^b   Zimmer, Matthew ^a   Hanchuk, Stephanie ^a   O'Bara, Melanie A ^b   Sadiq, Saud ^c   Sim, Fraser J ^b   Goldman, James ^d   Fossati, Valentina ^a  

^a New York Stem Cell Foundation Laboratory   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c Multiple Sclerosis Research Center of New York Inc   (United States)

^d NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOID; SMAD PROTEIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; NERVE PROTEIN; OLIG2 PROTEIN, HUMAN; RAG2 PROTEIN, MOUSE; RETINOIC ACID; SONIC HEDGEHOG PROTEIN;

ADULT; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CELL THERAPY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBER; OLIGODENDROGLIA; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REMYELINIZATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; CELL CULTURE; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOUSE; MYELIN SHEATH; PATHOLOGY; TRANSPLANTATION; XENOGRAFT;

ANIMALS; AXONS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN; CELL DIFFERENTIATION; CELLS, CULTURED; DNA-BINDING PROTEINS; FEMALE; HEDGEHOG PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; SMAD PROTEINS; TRANSPLANTATION, HETEROLOGOUS; TRETINOIN;

EID: 84924219729     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2014.06.012     Document Type: Article

References (28)

1. W.F. Alsanie, J.C. Niclis, and S. Petratos Human embryonic stem cell-derived oligodendrocytes: protocols and perspectives Stem Cells Dev. 22 2013 2459 2476
2. J. Antel, S. Antel, Z. Caramanos, D.L. Arnold, and T. Kuhlmann Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity? Acta Neuropathol. 123 2012 627 638
3. S.M. Chambers, C.A. Fasano, E.P. Papapetrou, M. Tomishima, M. Sadelain, and L. Studer Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling Nat. Biotechnol. 27 2009 275 280
4. J.E. Gil, D.H. Woo, J.H. Shim, S.E. Kim, H.J. You, S.H. Park, S.H. Paek, S.K. Kim, and J.H. Kim Vitronectin promotes oligodendrocyte differentiation during neurogenesis of human embryonic stem cells FEBS Lett. 583 2009 561 567
5. S.A. Goldman, M. Nedergaard, and M.S. Windrem Glial progenitor cell-based treatment and modeling of neurological disease Science 338 2012 491 495
6. S.S.W. Han, L.A. Williams, and K.C. Eggan Constructing and deconstructing stem cell models of neurological disease Neuron 70 2011 626 644
7. S.L. Hauser, J.R. Chan, and J.R. Oksenberg Multiple sclerosis: Prospects and promise Ann. Neurol. 74 2013 317 327
8. B.Y. Hu, Z.W. Du, X.J. Li, M. Ayala, and S.C. Zhang Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects Development 136 2009 1443 1452
9. B.Y. Hu, Z.W. Du, and S.C. Zhang Differentiation of human oligodendrocytes from pluripotent stem cells Nat. Protoc. 4 2009 1614 1622
10. Z. Hu, T. Li, X. Zhang, and Y. Chen Hepatocyte growth factor enhances the generation of high-purity oligodendrocytes from human embryonic stem cells Differentiation 78 2009 177 184
11. M. Izrael, P. Zhang, R. Kaufman, V. Shinder, R. Ella, M. Amit, J. Itskovitz-Eldor, J. Chebath, and M. Revel Human oligodendrocytes derived from embryonic stem cells: effect of noggin on phenotypic differentiation in vitro and on myelination in vivo Mol. Cell. Neurosci. 34 2007 310 323
12. I. Jakovcevski, R. Filipovic, Z. Mo, S. Rakic, and N. Zecevic Oligodendrocyte development and the onset of myelination in the human fetal brain Front Neuroanat 3 2009 5
13. S. Lee, S.Y. Chong, S.J. Tuck, J.M. Corey, and J.R. Chan A rapid and reproducible assay for modeling myelination by oligodendrocytes using engineered nanofibers Nat. Protoc. 8 2013 771 782
14. Y. Liu, P. Jiang, and W. Deng OLIG gene targeting in human pluripotent stem cells for motor neuron and oligodendrocyte differentiation Nat. Protoc. 6 2011 640 655
15. R.H. Miller, K. Dinsio, R. Wang, R. Geertman, C.E. Maier, and A.K. Hall Patterning of spinal cord oligodendrocyte development by dorsally derived BMP4 J. Neurosci. Res. 76 2004 9 19
16. G.I. Nistor, M.O. Totoiu, N. Haque, M.K. Carpenter, and H.S. Keirstead Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation Glia 49 2005 385 396
17. B.G. Novitch, H. Wichterle, T.M. Jessell, and S. Sockanathan A requirement for retinoic acid-mediated transcriptional activation in ventral neural patterning and motor neuron specification Neuron 40 2003 81 95
18. R. Patani, A.J. Hollins, T.M. Wishart, C.A. Puddifoot, S. Alvarez, A.R. de Lera, D.J. Wyllie, D.A. Compston, R.A. Pedersen, and T.H. Gillingwater et al. Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground state Nat. Commun. 2 2011 214
19. A. Pouya, L. Satarian, S. Kiani, M. Javan, and H. Baharvand Human induced pluripotent stem cells differentiation into oligodendrocyte progenitors and transplantation in a rat model of optic chiasm demyelination PLoS One 6 2011 e27925
20. C.M. Rice, D. Cottrell, A. Wilkins, and N.J. Scolding Primary progressive multiple sclerosis: progress and challenges J. Neurol. Neurosurg. Psychiatry 84 2013 1100 1106
21. F.J. Sim, C. Zhao, W.W. Li, A. Lakatos, and R.J. Franklin Expression of the POU-domain transcription factors SCIP/Oct-6 and Brn-2 is associated with Schwann cell but not oligodendrocyte remyelination of the CNS Mol. Cell. Neurosci. 20 2002 669 682
22. F.J. Sim, C.R. McClain, S.J. Schanz, T.L. Protack, M.S. Windrem, and S.A. Goldman CD140a identifies a population of highly myelinogenic, migration-competent and efficiently engrafting human oligodendrocyte progenitor cells Nat. Biotechnol. 29 2011 934 941
23. B. Song, G. Sun, D. Herszfeld, A. Sylvain, N.V. Campanale, C.E. Hirst, S. Caine, H.C. Parkington, M.A. Tonta, and H.A. Coleman et al. Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis Stem Cell Res. (Amst.) 8 2012 259 273
24. S.R.L. Stacpoole, S. Spitzer, B. Bilican, A. Compston, R. Karadottir, S. Chandran, and R.J.M. Franklin High yields of oligodendrocyte lineage cells from human embryonic stem cells at physiological oxygen tensions for evaluation of translational biology Stem Cell Rep. 1 2013 437 450
25. S. Wang, J. Bates, X. Li, S. Schanz, D. Chandler-Militello, C. Levine, N. Maherali, L. Studer, K. Hochedlinger, M. Windrem, and S.A. Goldman Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination Cell Stem Cell 12 2013 252 264
26. L. Warren, P.D. Manos, T. Ahfeldt, Y.H. Loh, H. Li, F. Lau, W. Ebina, P.K. Mandal, Z.D. Smith, and A. Meissner et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA Cell Stem Cell 7 2010 618 630
27. M.S. Windrem, S.J. Schanz, M. Guo, G.F. Tian, V. Washco, N. Stanwood, M. Rasband, N.S. Roy, M. Nedergaard, and L.A. Havton et al. Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse Cell Stem Cell 2 2008 553 565
28. M. Yamada, B. Johannesson, I. Sagi, L.C. Burnett, D.H. Kort, R.W. Prosser, D. Paull, M.W. Nestor, M. Freeby, and E. Greenberg et al. Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells Nature 510 2014 533 536 10.1038/nature13287